IRF1 suppresses gastric tumorigenesis via dual PI3K/AKT-ERK pathway modulation and functional antagonism of oncogenic MX2
Cellular Oncology · 2026
DOI: 10.1007/s13402-025-01134-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2026. Verfasst von Wenjing Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Interferon Regulatory Factor-1, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wenzhou Municipal Science and Technology Bureau, National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
- Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, China.
- Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital, Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, China. wzxxy@wmu.edu.cn.
- Wenzhou Key Laboratory of Cancer-related Pathogens and Immunity, Zhejiang International Cooperation Base for Tumor-Associated Pathogen and Host Interaction, Institute of Molecular Virology and Immunology, Department of…
- Department of Gastrointestinal Surgery, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China. 13968888872@163.com.
Förderung
- Wenzhou Municipal Science and Technology Bureau
- National Natural Science Foundation of China
- Key Research and Development Program of Zhejiang Province
Zitieren
APA
Chen, W., Lou, N., Chen, X., Hu, X., Mao, C., Yang, J., Cheng, J., Chen, C., Xue, X., & Shen, X. (2026). IRF1 suppresses gastric tumorigenesis via dual PI3K/AKT-ERK pathway modulation and functional antagonism of oncogenic MX2. Cellular Oncology. https://doi.org/10.1007/s13402-025-01134-w
Vancouver
Chen W, Lou N, Chen X, Hu X, Mao C, Yang J, et al. IRF1 suppresses gastric tumorigenesis via dual PI3K/AKT-ERK pathway modulation and functional antagonism of oncogenic MX2. Cellular Oncology. 2026. doi:10.1007/s13402-025-01134-w
BibTeX
@article{Chen2026,
author = {Chen, Wenjing and Lou, Neng and Chen, Xietao and Hu, Xianjing and Mao, Chenchen and Yang, Jiaqi and Cheng, Jun and Chen, Chenbin and Xue, Xiangyang and Shen, Xian},
title = {IRF1 suppresses gastric tumorigenesis via dual PI3K/AKT-ERK pathway modulation and functional antagonism of oncogenic MX2},
journal = {Cellular Oncology},
year = {2026},
doi = {10.1007/s13402-025-01134-w}
}
EUVIMED